Search Results - "Degraeuwe, Pieter L"

Refine Results
  1. 1

    The bioavailability and maturing clearance of doxapram in preterm infants by Flint, Robert B., Simons, Sinno H. P., Andriessen, Peter, Liem, Kian D., Degraeuwe, Pieter L. J., Reiss, Irwin K. M., Ter Heine, Rob, Engbers, Aline G. J., Koch, Birgit C. P., Groot, Ronald de, Burger, David M., Knibbe, Catherijne A. J., Völler, Swantje

    Published in Pediatric research (01-04-2021)
    “…Background Doxapram is used for the treatment of apnea of prematurity in dosing regimens only based on bodyweight, as pharmacokinetic data are limited. This…”
    Get full text
    Journal Article
  2. 2

    Intrauterine Growth Restriction and Patent Ductus Arteriosus in Very and Extremely Preterm Infants: A Systematic Review and Meta-Analysis by Villamor-Martinez, Eduardo, Kilani, Mohammed A, Degraeuwe, Pieter L, Clyman, Ronald I, Villamor, Eduardo

    Published in Frontiers in endocrinology (Lausanne) (08-02-2019)
    “…It is generally accepted that intrauterine growth restriction (IUGR) increases morbidity and mortality among very preterm neonates. However, evidence is…”
    Get full text
    Journal Article
  3. 3

    A failed attempt to conduct an individual patient data meta-analysis by Jaspers, Gerald J, Degraeuwe, Pieter L J

    Published in Systematic reviews (04-09-2014)
    “…A study-level meta-analysis has shown that proton magnetic resonance spectroscopy is a promising prognostic marker in neonatal hypoxic-ischemic encephalopathy…”
    Get full text
    Journal Article
  4. 4

    Pleural effusion due to intra‐abdominal extravasation of parenteral nutrition by Been, Jasper V., Degraeuwe, Pieter L.J.

    Published in Pediatric pulmonology (01-10-2008)
    “…An 8‐week‐old preterm boy experienced respiratory deterioration due to unilateral pleural effusion. Intra‐abdominal extravasation of parenteral fluid with…”
    Get full text
    Journal Article
  5. 5

    Chorioamnionitis appears not to be a Risk Factor for Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis by Behbodi, Elham, Villamor-Martínez, Eduardo, Degraeuwe, Pieter L. J., Villamor, Eduardo

    Published in Scientific reports (28-11-2016)
    “…The contribution of chorioamnionitis (CA) to mortality and morbidity in preterm infants is difficult to assess because observational studies frequently present…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Protein binding of flucloxacillin in neonates by PULLEN, Joyce, STOLK, Leo M. L, DEGRAEUWE, Pieter L. J, VAN TIEL, Frank H, NEEF, Cees, ZIMMERMANN, Luc J. I

    Published in Therapeutic drug monitoring (01-06-2007)
    “…The isoxazolyl penicillins, including flucloxacillin, have the highest levels of plasma protein binding among the semisynthetic penicillins. Because only the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates by PULLEN, Joyce, DE ROZARIO, Lindsay, STOLK, Leo M. L, DEGRAEUWE, Pieter L. J, VAN TIEL, Frank H, ZIMMERMANN, Luc J. I

    Published in Therapeutic drug monitoring (01-06-2006)
    “…In total 235 flucloxacillin total (free+protein bound) plasma concentrations were determined in 55 neonates (gestational age 26 to 42 weeks, postnatal age 0 to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Pharmacokinetics of intravenous rifampicin (ifampin) in neonates by PULLEN, Joyce, STOLK, Leo M. L, DEGRAEUWE, Pieter L. J, VAN TIEL, Frank H, NEEF, Cees, ZIMMERMANN, Luc J. I

    Published in Therapeutic drug monitoring (01-10-2006)
    “…Few reports have addressed neonatal rifampicin plasma concentrations and data on neonatal rifampicin pharmacokinetics are completely lacking. Therefore, plasma…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Population pharmacokinetics and dosing of amoxicillin in (Pre)term neonates by PULLEN, Joyce, STOLK, Leo M. L, NIEMAN, Fred H. M, DEGRAEUWE, Pieter L. J, VAN TIEL, Frank H, ZIMMERMANN, Luc J. I

    Published in Therapeutic drug monitoring (01-04-2006)
    “…Amoxicillin plasma concentrations, pharmacokinetic parameters, and the influence of demographic, anthropometric, and clinical covariates were investigated in…”
    Get full text
    Journal Article
  20. 20